chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient is a 46 yo I female with no sig PMH who reports the onset of fever, body aches and chills on Saturday 1/9 after receiving dose#2 of the Pfizer COVID Vaccine on 1/8 24 hours prior. Her temp went up to 100.4. She took Tylenol and motrin with subsequent resolution of symptoms except some slight body aches and the onset yesterday of bilateral stocking like paresthesia in LE's. As the body aches improved, she noticed the paresthesias more although they have lessened somewhat today. No prior history of COVID. Allgergies: NKA Meds: as above SH: Tob: none. ASSESSMENT Vaccine Reaction to COVID. PLAN Follow up with OMS tomorrow or prn.
Abnormal menstrual cycle started on June 25, the day after dose 2; she already had a period June 10-16. This involved increasingly heavy bleeding, with large blood clots. My daughter became very pale, weak on the morning of Mon, June 28, she fainted, then vomited. Made dr appt and got bloodwork. Started her on iron supplements. Dr said the hemoglobin was at 10.6, but had us get blood checked 3 more times, lowest hemoglobin was at 7.3.
rash on her abdomen and chest that went away after 24hours; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on her abdomen and chest that went away after 24hours) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 008A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021, the patient experienced RASH (rash on her abdomen and chest that went away after 24hours). On 07-Feb-2021, RASH (rash on her abdomen and chest that went away after 24hours) had resolved.            No treatment informations were reported
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Mar2021 as dose 1, single (Lot number: ER8727), in left arm, on 16Apr2021 as dose 2, single (Lot number: ER8731), in left arm and on 03Jan2022 as dose 3 (booster), single (Lot number: FJ1611) at the age of 59 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Fibromyalgia" (unspecified if ongoing). Concomitant medication(s) included: DETROL, start date: 01Jan2020; COZAAR, start date: 15Jul2022; VITAMIN D2, start date: 30Nov2020; LIPITOR, start date: 01Jan2020, stop date: 22Nov2022; ZYDUS, start date: 01Jan2020, stop date: 22Nov2022; VITAMIN D3, start date: 01Jan2019; SPRING VALLEY B100 COMPLEX, start date: 01Jan2019; KRILL OIL, start date: 01Jan2020; CYMBALTA, start date: 01Jan2019; CLARITIN [LORATADINE], start date: 01Jan2018. Past drug history included: Codeine, reaction(s): "Drug Allergy"; Povidine, reaction(s): "Drug Allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Nov2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19: the patient received treatment with Paxlovid from 24Nov2022 to 25Nov2022 and she stated that she had already limited taste and smell from previous COVID (Sep2021) but after taking first am dose she had a terrible taste concentrating on the left posterior portion of her tongue that continued all day. After taking the second pm dose, the terrible taste heightened and her upper lip became puffy and numb. She immediately took liquid Benadryl to stop the reaction. She then had intestinal distress and flu like symptoms. Chills, sweats, super exhausted. Slept for 1.5hrs. Woke up feeling sluggish and not herself. The terrible taste lingered until 24hrs after first am dose. Started to dissipate 27hrs after onset. She didn't have any of those symptoms prior to taking this medication. She did not continue to take Paxlovid on day 2.
she tested positive for the virus.; she tested positive for the virus.; developed some allergies; This is a spontaneous report from a Non contactable consumer (patient's mother). A 19-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, solution for injection, lot number and expiry date were not provided), via an unspecified route of administration, on 25Mar2021, as a single dose for COVID-19 immunization. Patient's medical history and concomitant medications were not reported. It was reported that the patient had some allergies without fever on 03Apr2021. Patient's mother mentioned her daughter took some allergy medication and it was resolved thereafter. However, her husband got tested positive for COVID19 infection on last Saturday, 10Apr2021 and out of curiosity, her daughter also took the same test on Sunday, 11Apr2021 and came back positive on Monday, 12Apr2021. Patient was scheduled to take her second shot on Thursday, 15Apr2021 and wanted to know if her daughter should proceed in taking the shot given that she tested positive for the virus. They referred to HCP for further clinical recommendation as to whether or not her daughter should proceed in taking the second dose of the vaccine given her current diagnosis. Outcome of the event hypersensitivity was recovered on an unknown date and for all other events, it was unknown.  No follow-up attempts are possible. Information about batch and lot number cannot be obtained.
No adverse event happened. The syringe used was defective and the patient received less than half the dose.
Information has been received from a healthcare worker (a certified medical assistant) referring to an unspecified number of patients of unknown age and gender. No concurrent conditions, medical history or drug allergies were reported. On 18-JUN-2015, the patients were vaccinated with improperly stored PROQUAD (Merck) (lot# also reported as L005297 with expired date 17-AUG-2016) (dosing regimen and route unknown). No concomitant medications were provided. No adverse effects were reported. Lot verification result has been received on 10-JUL-2015 and lot number L005297 with an expiry date of 17-AUG-2016 has been validated for PROQUAD (Merck). All telephone attempts to obtain follow-up information on 03-AUG-2015 have been unsuccessful. Follow up information has been received from a telephone call on 05-AUG-2015. The Certified Medical Assistant reported that she would have to research the request made for patient identifiers, lot number, expiration date and dates of vaccination. Follow-up information has been received from the medical assistant's clinic on 22-OCT-2015, regarding the 4-year-old patient of unknown gender. On 10-JUL-2015, the patient was vaccinated with a dose of PROQUAD (Merck), lot # was confirmed to be L005297. This is one of several reports received from the same reporter. Additional information has been requested. Patient's details, product, event information and narrative were updated.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Nurse). The reporter is the patient.  A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 09Aug2022 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 56 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Optic neuritis" (unspecified if ongoing). Patient had no known allergies. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2022, outcome "recovered" (17Sep2022) and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (17Sep2022) Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19 with Paxlovid from 13Sep2022 to 18Sep2022. Had a negative test and all symptoms resolved by 17Sep2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information, the reported events DRUG INEFFECTIVE and COVID-19 cannot be excluded for the suspect drug BNT162b2.
I was having Syncope events since 2007 while in the military. since march april may the migraines and syncopic events have gotten worse. The syncope events frome 4 to 5 a month to falls 3 to4 times a week sometimes leading to ER visits due to bruising or head trauma.
I tested positive for COVID-19 on 11/30/22. I had a runny nose, cough, headache, fever, sore throat, and sneezing. I took an at home test and tested positive. I called my doctor and he prescribed 5 days' worth of PAXLOVID. I have one more dose to take and then I am done. I am feeling much better now.
I63.9 - Cerebrovascular accident (CVA), unspecified mechanism (CMS/HCC) R29.810 - Facial weakness
Given at too young an age.  Came in for Shingles shot because brother had shingles and he didn't want to experience that.  I didn't check his age
Pfizer vaccine was administered outside of our facility - reported by patient- ? NO LOT NUMBER WERE SUPPLIED ---------------------------------------------------------------------------------------------------------------- J96.00 ACUTE RESPIRATORY FAILURE 5/14/2021 HYPOVOLEMIA R09.02 HYPOXEMIA 4/30/2021 HYPOVOLEMIA J96.00 ACUTE RESPIRATORY FAILURE 5/14/2021 CHF EXACERBATION, UNSPECIFIED R09.02 HYPOXEMIA 4/30/2021 CHF EXACERBATION, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 5/14/2021 HEART FAILURE W REDUCED LVEF 41-49%, UNSPECIFIED ACUITY R09.02 HYPOXEMIA 4/30/2021 HEART FAILURE W REDUCED LVEF 41-49%, UNSPECIFIED ACUITY
I am a lactating mama who feeds two babies. After receiving the first dose of the Moderna vaccine my milk production drastically decreased. I have been only having about half of the milk needed for just one of the children. With drinking lactation tea and pumping I am able to get back to just enough for one baby.  I am still at best half the volume of breast milk production from pre vaccine.
29APR96 pt recv vax&30APR96 pt woke up 5AM&noticed 6-7cm reddened,knot,sl elevated area on rt deltoid where inj given;c/o itching,mod pain,& area being hot;another smaller area proximally to larger area presented w/same s/s
rash on Hands, elbows and knees, that is Painful, Tender. Severity: Pain level (5)/10
Vaccine given at 11 AM; starting swelling around 10 PM, worse in the morning. Heat at local reaction and itching. No pain. 80mm wheal.
Pt recvd 3 doses of Engerix-B on 29AUG90; & dose 2 on 2OCT90, dose 3 date unk; pt was a non seroconverter;
Vaccinated twice with Moderna. Both times I had an allergic reaction; Metallic taste in mouth; My lips and right check were tingling; Nausea; First shot: headache; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Vaccinated twice with Moderna. Both times I had an allergic reaction), DYSGEUSIA (Metallic taste in mouth), PARAESTHESIA (My lips and right check were tingling), NAUSEA (Nausea) and HEADACHE (First shot: headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Vaccinated twice with Moderna. Both times I had an allergic reaction), DYSGEUSIA (Metallic taste in mouth), PARAESTHESIA (My lips and right check were tingling), NAUSEA (Nausea) and HEADACHE (First shot: headache). At the time of the report, HYPERSENSITIVITY (Vaccinated twice with Moderna. Both times I had an allergic reaction) and PARAESTHESIA (My lips and right check were tingling) outcome was unknown and DYSGEUSIA (Metallic taste in mouth), NAUSEA (Nausea) and HEADACHE (First shot: headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  No treatment medication was reported   This case was linked to MOD-2021-315328 (Patient Link).   Reporter did not allow further contact
This spontaneous report as received from a Healthcare worker reported that PEDVAXHIB were exposed to unspecified temperature conditions during a power failure for an unspecified period of time, were then administered to unspecified patients on unspecified dates. The indication, dose, route and lot # of the vaccine was not reported. No concomitant medications were reported. No adverse effect reported. At the report time the outcome of event was unknown. It was unknown if the patient sought medical attention. All telephone attempts to obtain follow-up information have been unsuccessful. This is one of several reports received from the same source. Additional information has been requested. AE term was amended. PT was changed to incorrect storage of drug.
raised, itchy swelling of left wrist and hand; this swelling felt hot raised hive-like itchy swellings elsewhere on the body, some bigger than 8 centimeters in diameter
10 x 10cm red well circumcised raised firm lesion left thigh (DTaP given).
Severe myalgia across lower back approximately 48 hrs after administration.  Treated with NSAID Resolved in about 36 hours.
Patient is having an extremely sore arm that has lasted for 7 days and counting. Patient states it is getting better slowly and was instructed to call back or see doctor if her arm does not continue to improve.
injured back; This spontaneous case was reported by a consumer and describes the occurrence of BACK INJURY (injured back) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]) for Back injury.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK INJURY (injured back). At the time of the report, BACK INJURY (injured back) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had two blood transfusions after receiving the first dose of vaccine. No treatment medication was reported.
Fever, Chills, Headache, Nausea, Muscle aches, and Exhaustion 2 day timeframe.
Pt had dizziness and shaking  that began a few minutes after fist dose.  After about 10 minutes with legs elevated, she began to have a metallic taste in mouth, tingly right cheek, right neck, then arm. Called 911.
Red, itchy, raised area at injection site, about 2 inches in circular area.  No pain, just red, raised and itchy.
This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the patient. A 35 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Jan2021 (Lot number: EL3249) at the age of 35 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Eustachian tube disorder" (unspecified if ongoing), notes: other medical history: Eustachian tube disorder.; "ADHD" (unspecified if ongoing), notes: other medical history: ADHD. "benign tumor removed from salivary gland" (unspecified if ongoing), notes: other medical history: tumor removed from salivary gland; "burning throat disorder." (unspecified if ongoing), notes: other medical history: burning throat disorder. "Burning Throat Disorder", start date: Mar2020 (unspecified if ongoing), notes: Last year I started suffering from a rare Burning Throat Disorder in March, 2020 after a long bout of strep throat. At the time I took 20 mg of Nortriptyline for the pain. Concomitant medications included: NORTRIPTYLINE; DEXILANT. The following information was reported: OROPHARYNGEAL PAIN (non-serious) with onset 15Jan2021 19:00, outcome "recovering", described as "my throat became extremely sore"; THROAT IRRITATION (non-serious) with onset 15Jan2021 19:00, outcome "recovering", described as "burning in my throat". The events "my throat became extremely sore" and "burning in my throat" were evaluated at the physician office visit. Therapeutic measures were taken as a result of oropharyngeal pain, throat irritation. Additional information: Patient had Known allergies: No. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Reporter stated that Last year I started suffering from a rare Burning Throat Disorder in March 2020 after a long bout of strep throat. At the time I took 20 mg of Nortriptyline for the pain. After I got the vaccine, my throat became extremely sore like I had strep again and the Nortriptyline stopped working completely. I had to add additional nerve pain medications and take Tylenol for the pain. After three days the sore throat went away but the burning in my throat remained and at an even higher burning level. Eventually the Nortriptyline started working again but my pain is still worse than before the vaccine. I still got the second shot and thankfully did not notice an increase in pain again but did have a sore throat for a day once more. My neurologist wanted me to report this to you as we try to find answers for my Burning Throat Disorder altogether. No follow-up attempts are possible. No further information is expected.
Fever, vomiting, diarrhea, and fussiness.  3 cm of swelling and erythema at injection site. - Right thigh.
tested positive for flu; Initial information received on 27-Oct-2021 regarding an unsolicited valid serious case from consumer/non-health care professional via social media.  This case involves a patient (unknown age and gender) who had tested positive for flu (influenza), after receiving INFLUENZA VACCINE .  It was unknown if the patient had any medical history, concomitant disease or risk factor.  The patient's past medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient had tested positive for flu (influenza), (serious) [unknown latency] following the administration of vaccine.  It was unknown if the patient experienced any additional symptoms/events.  It was unknown if there were other relevant laboratory data/results available.  It was not reported if the patient received a corrective treatment.  At time of reporting, the outcome was unknown for the reported event.  Information on the batch number was requested.; Sender's Comments: This case involves a patient who had influenza after vaccination with INFLUENZA VACCINE (produced by unknown manufacturer). The time to onset is unknown. Furthermore information regarding other relevant conditions and previous vaccinations of the patient will be needed to fully assess the case. Based upon the reported information, the role of a vaccine cannot be assessed.
pt got red, painful and hot to the touch went to md's office and pt got some meds for the side effects. the pt is fine now will call md to change the antibiotic md gave bc she is allergic to blue dye
After my first vaccine, I experienced the worst kind of flu symptoms all day long. They lasted for about 28-30 hours. My second shot was fine, and I had no side effects. I did have a period after I got my first dose, and I don?t get periods anymore due to my IUD contraception.
Information has been received from a physician concerning a 16 year old (also reported as 15 year old) female who on an unspecified date was vaccinated with a first dose of GARDASIL (route and administration site not reported), and was vaccinated with a second dose of GARDASIL (route and administration site not reported) (also reported as having been given the week of 08-AUG-2008).  Two months after she received the initial vaccine, the patient developed memory loss.  It was also reported that shortly after the second vaccination, the patient developed paralysis of her arm.  The patient was evaluated by her pediatrician, whose initial impression was that the symptoms may have been a psychology issue.  Following this office evaluation the patient experienced other symptoms such as vomiting and was evaluated at an emergency room.  The patient underwent numerous unspecified tests and saw unspecified specialists (results not provided).  Subsequently the patient was hospitalized for encephalitis and has since been discharged.  The physician doubts there was a link between the diagnosis of encephalitis and the vaccination.  The physician reported that someone at the emergency room may have suggested to the patient's mother that there may be a link between the diagnosis and GARDASIL.  The patient's encephalitis persisted.  The physician considered the encephalitis to be disabling.  Additional information has been requested.
Numb toes, high fever, extreme body aches and pain, chills, cough, headache. Lasted 36 hours.
I got the vaccine at 7:30 pm, the next day at 9am my legs began to itch, then my arms began to itch a few hours later. The next day my neck and some parts of my stomach are also itchy. There a small little bumps in the areas where I am itchy. I took Benadryl at 10pm, and the the itch subsided for the most part but some areas were jot effected. Today, the areas have progressively spread through out my body, I took more Benadryl and it helped for a few hours and then took another one. After 4 hours I took another Benadryl. Yet I am still itchy all over again.
Patient complained of wheezing & chest tightness. Onsite EMS was called vitals  BP 158/97 HR 75.  EMS took patient to Recieving Hospital.
No adverse event; Administered the second Moderna Covid shot in the series but accidentally gave the bivalent booster; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (Administered the second Moderna Covid shot in the series but accidentally gave the bivalent booster) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On 29-Sep-2022, the patient received second dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 29-Sep-2022, the patient experienced WRONG PRODUCT ADMINISTERED (Administered the second Moderna Covid shot in the series but accidentally gave the bivalent booster). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Administered the second Moderna Covid shot in the series but accidentally gave the bivalent booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Administered the second Moderna Covid shot in the series but accidentally gave the bivalent booster).    No concomitant medication was reported.    Caller stated, one of the technicians was administering the second Moderna Covid shot in the series and accidentally gave the bivalent booster. No treatment information was reported.